This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.
Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells, which leads to recurrent vaso-occlusive crises (VOC). These painful episodes are among the most common causes of hospitalization and are associated with significant morbidity in pediatric patients. Despite ongoing improvements in the management of sickle cell disease, there is still limited data describing the incidence, risk factors, and clinical outcomes of VOC in children within our population. This study is designed to retrospectively analyze medical records of pediatric patients with sickle cell disease at Faculty of Medicine, Assiut University. The primary aim is to estimate the incidence of vaso-occlusive crises and to identify the most frequent complications. Secondary objectives include evaluating treatment approaches, length of hospital stay, and clinical outcomes. Findings from this study are expected to provide valuable insights that may help improve clinical care strategies and preventive measures for affected children.
Study Type
OBSERVATIONAL
Enrollment
25
retrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.
Assiut University
Asyut, Egypt
Incidence of vaso-occlusive crisis in pediatric sickle cell patients
Frequency of vaso-occlusive crisis episodes will be identified through retrospective chart review of pediatric sickle cell patients.
Time frame: Retrospective review of medical records from 2019 to 2024
Complications associated with vaso-occlusive crisis (e.g., acute chest syndrome, stroke, infections)
Complications related to vaso-occlusive crisis will be identified and documented from patient records.
Time frame: Throughout the study period (2019-2024)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.